IP Library Granted Patent US 11,071,706
Granted Patent B2
US 11,071,706 · App. 16/089,510 · Granted Jul 27, 2021

Cosmetic composition containing, as active ingredient, albumin, hyaluronic acid or collagen in cell culture medium

Inventors: Chan Wha Kim (Seoul, KR); Young Joon Kim (Tenafly, NJ)
Assignee: BIOCOZ GLOBAL KOREA CORP.
A61K8/65A61K8/19A61K8/36A61K8/64A61K8/673A61K8/675A61K8/735A61K38/385A61K38/39A61K47/02A61K47/12A61K47/22A61K47/26A61P17/00A61P27/02A61Q19/005A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,071,706
App. No.
16/089,510
Granted
Jul 27, 2021
Kind
B2
Abstract

The present invention relates to a cosmetic or pharmaceutical composition containing a cell culture medium and, as an active ingredient, albumin, hyaluronic acid or collagen. The composition according to the present invention can be useful as a cosmetic or pharmaceutical composition for alleviating, preventing or treating skin wounds, skin diseases or skin conditions, by increasing the recovery capability of cells.

Claims (16)

1. A method for improving skin condition of a subject, comprising administering a cosmetic composition to the subject,

said composition comprising

a cell culture medium; and

one or more selected from the group consisting of albumin, hyaluronic acid, and collagen;

wherein the cell culture medium comprises an amino acid component, a vitamin component, and an inorganic salt component, and

wherein the amino acid component comprises 1 part by weight of serine, 0.2 to 1.2 parts by weight of glycine, 0.08 to 0.3 part by weight of L-alanine, 2 to 7 parts by weight of L-arginine hydrochloride, 0.2 to 0.9 part by weight of L-cysteine hydrochloride-monohydrate, 10 to 18 parts by weight of L-glutamine, 0.8 to 2.0 parts by weight of L-histidine hydrochloride-monohydrate, 1.0 to 5.0 parts by weight of L-lysine hydrochloride, 0.2 to 1.2 parts by weight of L-methionine, 0.2 to 1.2 parts by weight of L-proline, 1.0 to 5.0 parts by weight of L-threonine, and 1.0 to 5.0 parts by weight of L-valine, based on the 1 part by weight of serine.

2. The method of claim 1 , comprising applying the cosmetic composition to a target skin of the subject.

3. The method of claim 2 , wherein the subject is a mammal.

4. A method for preventing or treating a skin disorder in a subject in need thereof, comprising administering a pharmaceutical composition to the subject,

said composition comprising

a cell culture medium; and

one or more selected from the group consisting of albumin, hyaluronic acid, and collagen;

wherein the cell culture medium comprises an amino acid component, a vitamin component, and an inorganic salt component, and

wherein the amino acid component comprises 1 part by weight of serine, 0.2 to 1.2 parts by weight of glycine, 0.08 to 0.3 part by weight of L-alanine, 2 to 7 parts by weight of L-arginine hydrochloride, 0.2 to 0.9 part by weight of L-cysteine hydrochloride-monohydrate, 10 to 18 parts by weight of L-glutamine, 0.8 to 2.0 parts by weight of L-histidine hydrochloride-monohydrate, 1.0 to 5.0 parts by weight of L-lysine hydrochloride, 0.2 to 1.2 parts by weight of L-methionine, 0.2 to 1.2 parts by weight of L-proline, 1.0 to 5.0 parts by weight of L-threonine, and 1.0 to 5.0 parts by weight of L-valine, based on the 1 part by weight of serine.

5. The method of claim 4 , comprising applying the pharmaceutical composition to a target skin of the subject.

6. The method of claim 5 , wherein the subject is a mammal.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2026
From: BIOCOZ GLOBAL PTE. LTD.
To: BG PHARMACEUTICAL, INC.
Reel/Frame 075422/0955 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2022
From: BIOCOZ GLOBAL KOREA CORP.
To: BIOCOZ GLOBAL PTE. LTD.
Reel/Frame 062186/0944 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2018
From: KIM, CHAN WHA; KIM, YOUNG JOON
To: BIOCOZ GLOBAL KOREA CORP.
Reel/Frame 047006/0749 →
Continuity (2)
Provisional Application 62316948 · Apr 1, 2016
Related Publication 20200297613A1 · Sep 24, 2020